From January 1, 2022 to March 31, 2022, the company has repurchased 1,940,000 shares, representing 2.29% for $125 million. With this, the company has completed the repurchase of 1,940,000 shares, representing 2.29% for $125 million under the buyback announced on December 10, 2020.
Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.94 USD | +0.38% | -6.28% | -26.66% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 03 | Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.66% | 2.5B | |
-4.01% | 105B | |
-4.77% | 66.74B | |
+7.87% | 52.63B | |
+16.18% | 47.48B | |
0.00% | 39.68B | |
+7.17% | 27.78B | |
-1.23% | 26.27B | |
+3.80% | 26.11B | |
+12.35% | 25.38B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on December 10, 2020.